(a)
(b)
(c)
(d)
(e)
(f)
Figure 1: A case of high grade infiltrative urothelial carcinoma (a) presenting HER2 overexpression (b), pAKT (c) and pmTOR (d) expression, loss of PTEN expression (e), and high MIB1 labeling index (f). ((a) HE ×200; (b–f) IHC ×200).